In our Liberty Update this week, we highlight the latest illegal leak of thousands of supposedly confidential…
CFIF on Twitter CFIF on YouTube
ProPublica/IRS Leak: There's No Underlying "There" There

In our Liberty Update this week, we highlight the latest illegal leak of thousands of supposedly confidential Internal Revenue Service (IRS) taxpayer returns spanning over 15 years, confirming that the partisan and power-hungry IRS simply cannot be trusted to safeguard our sensitive records, let alone to begin collecting sensitive private information from nonprofit organizations on donors who contribute to them in violation of the First Amendment.

Getting to the substance of the ProPublica/IRS leaked documents themselves, former Senator Phil Gramm and U.S. Policy Metrics partner Mike Solon explain in The Wall Street Journal how there's nothing scandalous in the least in what they reveal:

ProPublica’s 'blockbuster' story showing that the wealthy 'pay income taxes that are only…[more]

June 18, 2021 • 04:40 PM

Liberty Update

CFIFs latest news, commentary and alerts delivered to your inbox.
CFIF Opposes State Attorneys General “March-In” Demand on Remdesivir Print
By CFIF Staff
Thursday, August 06 2020

ALEXANDRIA, VA – This week, a group of state attorneys general issued a joint letter to the United States Department of Health and Human Services (HHS), National Institutes of Health (NIH) and Food and Drug Administration (FDA) demanding that the federal government employ so-called “march-in” rights under the Bayh-Dole Act of 1980 to disregard Gilead Sciences, Inc.’s patent rights on its antiviral drug Remdesivir, or allow their states to do so.  The Center for Individual Freedom (CFIF) strongly opposes their demand.  

“If you seek to bring pharmaceutical innovation to a grinding halt, and deprive Americans of lifesaving drugs, the best way to do it is to flagrantly disregard patent protections for pharmaceutical innovators,” said Timothy Lee, CFIF’s Senior Vice President of Legal and Public Affairs.  “Unfortunately, that’s precisely the path that a misguided group of state attorneys general have decided to pursue.  Violating innovators’ patent rights won’t make drugs cheaper, it will only deprive consumers of potentially beneficial drugs entirely.  America currently produces two-thirds of all new drugs worldwide, and that’s because our nation honors and protects patent rights, it doesn’t violate them,” Lee added.    

“It’s particularly galling that the attorneys’ general seek to leverage the Bayh-Dole Act of 1980 to facilitate their scheme, and as we celebrate the law’s 40th anniversary to boot,” Lee continued.  “The Bayh-Dole Act was passed in order to extend patent rights to universities and nonprofit research entities whose research was assisted by federal funds, not weaken them.”  

Prior to Bayh-Dole, very few innovations partially funded by federal dollars were ever commercially pursued – only 390 in the year prior to its passage.  Forty years later, however, that number approaches 7,500, with over 420,000 inventions and 13,000 new startup enterprises formed.  

In the case of Remdesivir, Gilead Sciences has invested billions of dollars in research, development, testing and now manufacturing of the antiviral drug, including over $1 billion this year alone to expand manufacturing capacity both domestically and abroad.  Moreover, Remdesivir’s patents are held by Gilead Sciences, not other researchers or entities that received federal funding at various points in the drug’s creation and production.  Accordingly, Bayh-Dole doesn’t offer the legal means by which the attorneys general seek to achieve their counterproductive ends.  

Fortunately, HHS officials have expressed strict opposition to this scheme.  “CFIF strongly encourages the Trump Administration, HHS, NIH and FDA to maintain their rejection, and instead strengthen rather than limit patent rights for America’s world-leading pharmaceutical innovators, particularly in this time of critical societal need,” Lee concluded.  

CFIF is a constitutional and free market advocacy organization with over 300,000 supporters and activists nationwide.  

###

Quiz Question   
What is the current U.S. national debt?
More Questions
Notable Quote   
 
"Liberal activists fearful of Democrats losing control of the Senate are pushing for stalwart liberal Justice Stephen Breyer to retire this year but Democratic senators don't share their enthusiasm, knowing a fall confirmation battle could quickly become a partisan circus.Senators say it's entirely up to Breyer, who is 82 years old, to make a decision on when to step down from the high court. They…[more]
 
 
—Alexander Bolton, The Hill
— Alexander Bolton, The Hill
 
Liberty Poll   

Are your local schools currently facing open debate with parents regarding the introduction of radical leftist ideological positions into the curricula?